Follow the people · Insider
Maricel Apuli
Maricel Apuli files insider transactions with the SEC as a chief accounting officer of BridgeBio Pharma (BBIO). We hold 4 disclosed purchases and sales filed since 21 March 2025, 1 of them in the last 90 days.
- Files forBBIO
- Disclosed buys and sells4 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 19 March 2025 — 16 August 2026Chief Accounting Officer · BridgeBio Pharma (BBIO)20 Form 4 lines · source: SEC Form 4
Everything they disclosed
20 entries, newest first — one per disclosure report, one per Form 4 line- had shares withheld for tax on 4,714 shares of BridgeBio PharmaSEC Form 418 August 2026Common Stock · traded 16 August 2026 · filed 18 August 2026
- ▼ sold on the open market 2,000 shares of BridgeBio PharmaSEC Form 43 August 2026Common Stock · traded 30 July 2026 · filed 3 August 2026
- had shares withheld for tax on 4,714 shares of BridgeBio PharmaSEC Form 419 May 2026Common Stock · traded 16 May 2026 · filed 19 May 2026
- ▼ sold on the open market 2,000 shares of BridgeBio PharmaSEC Form 44 May 2026Common Stock · traded 30 April 2026 · filed 4 May 2026
- was granted 14,170 shares of BridgeBio PharmaSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- was granted 14,170 shares of BridgeBio PharmaSEC Form 420 March 2026Common Stock · traded 18 March 2026 · filed 20 March 2026
- ▼ sold on the open market 2,000 shares of BridgeBio PharmaSEC Form 427 February 2026Common Stock · traded 26 February 2026 · filed 27 February 2026
- ▼ sold on the open market 2,000 shares of BridgeBio PharmaSEC Form 427 February 2026Common Stock · traded 26 February 2026 · filed 27 February 2026
- had shares withheld for tax on 4,349 shares of BridgeBio PharmaSEC Form 418 February 2026Common Stock · traded 16 February 2026 · filed 18 February 2026
- ▼ sold on the open market 510 shares of BridgeBio PharmaSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- had shares withheld for tax on 4,349 shares of BridgeBio PharmaSEC Form 418 February 2026Common Stock · traded 16 February 2026 · filed 18 February 2026
- ▼ sold on the open market 510 shares of BridgeBio PharmaSEC Form 418 February 2026Common Stock · traded 17 February 2026 · filed 18 February 2026
- had shares withheld for tax on 2,003 shares of BridgeBio PharmaSEC Form 416 December 2025Common Stock · traded 12 December 2025 · filed 16 December 2025
- ▼ sold on the open market 2,000 shares of BridgeBio PharmaSEC Form 410 December 2025Common Stock · traded 8 December 2025 · filed 10 December 2025
- had shares withheld for tax on 4,781 shares of BridgeBio PharmaSEC Form 418 November 2025Common Stock · traded 16 November 2025 · filed 18 November 2025
- had shares withheld for tax on 4,781 shares of BridgeBio PharmaSEC Form 419 August 2025Common Stock · traded 16 August 2025 · filed 19 August 2025
- ▼ sold on the open market 1,000 shares of BridgeBio PharmaSEC Form 411 August 2025Common Stock · traded 7 August 2025 · filed 11 August 2025
- had shares withheld for tax on 4,780 shares of BridgeBio PharmaSEC Form 420 May 2025Common Stock · traded 16 May 2025 · filed 20 May 2025
- ▼ sold on the open market 1,026 shares of BridgeBio PharmaSEC Form 46 May 2025Common Stock · traded 2 May 2025 · filed 6 May 2025
- was granted 23,660 shares of BridgeBio PharmaSEC Form 421 March 2025Common Stock · traded 19 March 2025 · filed 21 March 2025
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.